Metsera Sees Stock Rally 54% Following $275M IPO

Seeking Alpha23minutes ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

GlobeNewswireJan 30 08:30 ET

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsJan 29 07:34 ET · Ratings

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy From Piper Sandler

TipRanksJan 29 07:29 ET · Ratings

Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease

Seeking AlphaJan 28 15:15 ET

Jonathan Wolleben's Positive Outlook on Structure Therapeutics, Inc. Driven by Unique Small Molecule Amylin Agonist and Promising Obesity Pipeline

TipRanksJan 24 10:05 ET